Delivery Order SPE2DR25D1107-SPE2DR26F8Z0D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $28,041.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S inhalers, with a completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $5,952.66 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price, non-competitive set-aside delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $57,155.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 11, 2025, with completion targeted for August 12, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $21,853.31 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,780.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive award, made without set-aside designation, is issued under an Indefinite Delivery Contract with DLA Troop Support Medical (contract value up to $999,999,999.00 through December 2026). Trelegy Ellipta is a combination respiratory maintenance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This $3,552.68 firm fixed-price delivery order, which is not set-aside restricted, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,768.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units). This is a non-set-aside, competitively awarded contract with a completion date of January 7, 2026, and performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,536.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is...
- The Defense Logistics Agency awarded a $1,837.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count). This is a non-set-aside competitive award to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D1107Indefinite Delivery Contract
- SPE2DR25D1107-SPE2DR26F8Z0DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,711.87 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units) on January 16, 2026, with completion expected by January 20, 2026. This firm fixed-price delivery order was issued on a non-set-aside basis under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used to treat chronic obstructive pulmonary disease, representing the type of specialty pharmaceutical products that AmerisourceBergen regularly supplies to support military and federal healthcare systems. This delivery order is executed under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which is valued at up to $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal agencies including the Department of Defense Health Agency and the U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to efficiently fulfill government requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains in support of military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.7k | 1/15/26 |